David Sugrue: Influence Statistics

David Sugrue

David Sugrue

David Sugrue, B.S., is a 2015 Pharm.D. candidate; Robin Bogner, M.S., Ph.D., is Associate Professor of Pharmaceutics; and Megan J. Ehret, Pharm.D., M.S., BCPP, is Associate ...

David Sugrue: Expert Impact

Concepts for which David Sugrue has direct influence: Hyperactivity disorder , Deficit hyperactivity , Disorder hyperactivity , Disorder adhd , Methylphenidate tablets , Nervous stimulants , Stimulants child .

David Sugrue: KOL impact

Concepts related to the work of other authors for which for which David Sugrue has influence: Excessive blinking , Hyperactivity disorder , Laboratory classroom setting , Dopamine compartmentalization , Mpd adolescence , Adults adhd , Young brain .

KOL Resume for David Sugrue

Year
2014

David Sugrue, B.S., is a 2015 Pharm.D. candidate; Robin Bogner, M.S., Ph.D., is Associate Professor of Pharmaceutics; and Megan J. Ehret, Pharm.D., M.S., BCPP, is Associate Professor of Pharmacy Practice, School of Pharmacy, University of Connecticut, Storrs

Prominent publications by David Sugrue

KOL-Index: 4620 . PURPOSE: Current literature on the safety and efficacy of various intermediate- and long-acting preparations of methylphenidate and dexmethylphenidate for pediatric attention-deficit/hyperactivity disorder (ADHD) is reviewed. SUMMARY: The efficacy of methylphenidate in controlling ADHD symptoms is firmly established. Given the drug's relatively short half-life in pediatric patients (about ...
Known for Hyperactivity Disorder | Adhd Symptoms | Attention Deficit | Extended Release

Key People For Hyperactivity Disorder

Top KOLs in the world
#1
JOSEPH Biederman
bipolar disorder attention deficit adults adhd
#2
Stephen V Faraone∗
hyperactivity disorder attention deficit children adhd
#3
Thomas J Spencer
hyperactivity disorder attention deficit adults adhd
#4
Russell A Barkley
hyperactivity disorder attention deficit hyperactive children
#5
James M Swanson
hyperactivity disorder children adhd attention deficit
#6
Jan K Buitelaar∗
hyperactivity disorder attention deficit adhd symptoms

David Sugrue, B.S., is a 2015 Pharm.D. candidate; Robin Bogner, M.S., Ph.D., is Associate Professor of Pharmaceutics; and Megan J. Ehret, Pharm.D., M.S., BCPP, is Associate Professor of Pharmacy Practice, School of Pharmacy, University of Connecticut